Source link : https://www.newshealth.biz/health-news/lebrikizumab-compared-with-dupilumab-in-atopic-dermatitis/
TOPLINE: In a network meta-analysis (NMA) from a living systematic review, lebrikizumab and dupilumab showed similar efficacy in patients with atopic dermatitis (AD). METHODOLOGY: Researchers evaluated data from an ongoing living systematic review and NMA (used to compare systemic medications) of 98 trials with 24,707 participants with moderate to severe AD who received systemic immunomodulatory […]
Author : News Health
Publish date : 2024-08-05 05:31:09
Copyright for syndicated content belongs to the linked Source.
Categories